Compare HCC & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HCC | MMSI |
|---|---|---|
| Founded | 2015 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.8B |
| IPO Year | 2017 | 1990 |
| Metric | HCC | MMSI |
|---|---|---|
| Price | $101.00 | $81.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $76.40 | ★ $106.13 |
| AVG Volume (30 Days) | ★ 750.1K | 745.0K |
| Earning Date | 02-12-2026 | 02-24-2026 |
| Dividend Yield | ★ 0.32% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.67 | ★ 1.95 |
| Revenue | $1,224,320,000.00 | ★ $1,477,128,000.00 |
| Revenue This Year | N/A | $13.60 |
| Revenue Next Year | $47.01 | $6.23 |
| P/E Ratio | $149.58 | ★ $42.18 |
| Revenue Growth | N/A | ★ 11.41 |
| 52 Week Low | $38.00 | $78.12 |
| 52 Week High | $105.35 | $111.45 |
| Indicator | HCC | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 79.63 | 40.07 |
| Support Level | $86.85 | $85.70 |
| Resistance Level | $105.35 | $94.75 |
| Average True Range (ATR) | 3.36 | 3.16 |
| MACD | 0.77 | -1.05 |
| Stochastic Oscillator | 77.05 | 15.30 |
Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.